Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study.

PLoS One · 2012 · PMC3338465 · PMID 22558238

Europe PMC DOI

hedged sentence

0.0190

closest p · 0.4× alpha

0.0190

boldest claim

The sentences

showed a trendp = 0.019actually significant

A McNemar test with a Bonferroni correction for multiple tests showed a trend toward the reduction of the proportion of patients with FSS score ≥4.5 after 1 ( p = 0.019) and 2 years ( p = 0.021) in comparison to baseline value.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.